KOSDAQ · Healthcare · ₩334B
₩8,540+3.02%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 5.0% · as of 26.10.27
Among 34 바이오 peers
Quarterly Revenue Growth
“이번 분기는 기존 사업 위에 해외 치료제 성장을 준비하는 구간입니다.”
In the company's words · 2026 2분기 filing